ZyVersa Therapeutics, Inc. Annual Depreciation in USD from 2022 to 2023

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: ZyVersa Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2022 to 2023.
ZyVersa Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $2.6K, unchanged year-over-year.
ZyVersa Therapeutics, Inc. annual Depreciation for 2023 was $10.4K, a 5.39% increase from 2022.

Depreciation, Annual (USD)

Depreciation, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$10.4K	+$532	+5.39%	Jan 1, 2023	Dec 31, 2023	10-K	2024-03-25
2022	$9.87K			Jan 1, 2022	Dec 12, 2022	10-K	2024-03-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.